Prostaglandin E1 in severe lower limb ischaemia: A double-blind controlled trial
Authors:
- 1 July 1984
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 71 (7) , 506-508
Abstract
Thirty patients with ischaemic ulceration or rest pain due to lower limb atherosclerosis were treated with intravenous prostaglandin E1 (PGE1) or placebo in a prospective double‐blind controlled trial. There was no significant improvement of rest pain, nor was PGE1 effective in promoting ulcer healing. This study provides no support for the use of intravenous PGE1 in the treatment of end‐stage lower limb atherosclerotic disease.Keywords
This publication has 13 references indexed in Scilit:
- Conservative treatment of inoperable arterial occlusions of the lower extremities with intra-arterial prostaglandin E1British Journal of Surgery, 1982
- Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.Annals of the Rheumatic Diseases, 1981
- Treatment of vasospastic disease with prostaglandin E1.BMJ, 1980
- Vasodilator Drugs in Peripheral Vascular DiseaseNew England Journal of Medicine, 1979
- Drug therapy in intermittent claudication: An objective assessment of the effects of three drugs on patients with intermittent claudicationBritish Journal of Surgery, 1978
- THE DISCOVERY OF PROSTACYCLIN – – – A FRESH INSIGHT INTO ARACHIDONIC ACID METABOLISM1977
- INTRAVENOUS PROSTAGLANDIN E1 IN SEVERE PERIPHERAL VASCULAR DISEASEThe Lancet, 1976
- Prostaglandin E 1 (PGE 1 in Peripheral ArteriographiesActa Radiologica. Diagnosis, 1973
- FEMORAL-ARTERY INFUSION OF PROSTAGLANDIN E1 IN SEVERE PERIPHERAL VASCULAR DISEASEThe Lancet, 1973
- Observations on the Effects of Infusion of Prostnglnndin E in ManActa Physiologica Scandinavica, 1959